Back to Results
First PageMeta Content
Boxed warning / Food and Drug Administration / Hazards / Pharmaceutical industry / Medical error / Patient safety / Medicine / Health / Piperazines


BLINCYTO™ (blinatumomab) Drug Class: Bispecific CD19-directed CD3 T-cell engager Amgen Inc.
Add to Reading List

Open Document

File Size: 516,65 KB

Share Result on Facebook
UPDATE